Testing effectiveness (Phase 2)Ended earlyNCT01605708
What this trial is testing
Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis
Who this might be right for
PruritusAtopic Dermatitis
Regeneron Pharmaceuticals 19